Cargando…

Exosomes in the Treatment of Pancreatic Cancer: A Moonshot to PDAC Treatment?

Pancreatic Ductal Adenocarcinoma (PDAC) constitutes a leading cause of cancer death globally. Its mortality remains unaltered despite the considerable scientific progress made in the fields of diagnostics and treatment. Exosomes comprise of small extracellular vesicles secreted by nearly all cells;...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papadakos, Stavros P., Dedes, Nikolaos, Pergaris, Alexandros, Gazouli, Maria, Theocharis, Stamatios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998433/ https://www.ncbi.nlm.nih.gov/pubmed/35408980 http://dx.doi.org/10.3390/ijms23073620

Ejemplares similares

The EPH/Ephrin System in Pancreatic Ductal Adenocarcinoma (PDAC): From Pathogenesis to Treatment
por: Papadakos, Stavros P., et al.
Publicado: (2023)

The EPH/Ephrin System in Colorectal Cancer
por: Papadakos, Stavros P., et al.
Publicado: (2022)

The Role of the NLRP3 Inflammasome in HCC Carcinogenesis and Treatment: Harnessing Innate Immunity
por: Papadakos, Stavros P., et al.
Publicado: (2022)

Utilizing Exosomal-EPHs/Ephrins as Biomarkers and as a Potential Platform for Targeted Delivery of Therapeutic Exosomes
por: Goutas, Dimitrios, et al.
Publicado: (2022)

The Clinical Impact of Death Domain-Associated Protein and Holliday Junction Recognition Protein Expression in Cancer: Unmasking the Driving Forces of Neoplasia
por: Pergaris, Alexandros, et al.
Publicado: (2023)

Extracellular Vesicles as Biomarkers Carriers in Bladder Cancer: Diagnosis, Surveillance, and Treatment
por: Georgantzoglou, Natalia, et al.
Publicado: (2021)

Challenging, Accurate and Feasible: CAF-1 as a Tumour Proliferation Marker of Diagnostic and Prognostic Value
por: Sykaras, Alexandros G., et al.
Publicado: (2021)

Moonshots for aging
por: Kumar, Sandeep, et al.
Publicado: (2020)

Unveiling the Yin-Yang Balance of M1 and M2 Macrophages in Hepatocellular Carcinoma: Role of Exosomes in Tumor Microenvironment and Immune Modulation
por: Papadakos, Stavros P., et al.
Publicado: (2023)

The EPH/Ephrin System in Gynecological Cancers: Focusing on the Roots of Carcinogenesis for Better Patient Management
por: Psilopatis, Iason, et al.
Publicado: (2022)

Histone Deacetylase Inhibitors: A Promising Therapeutic Alternative for Endometrial Carcinoma
por: Psilopatis, Iason, et al.
Publicado: (2021)

The Clinical Impact of the EPH/Ephrin System in Cancer: Unwinding the Thread
por: Pergaris, Alexandros, et al.
Publicado: (2021)

Thymic Epithelial Neoplasms: Focusing on the Epigenetic Alterations
por: Psilopatis, Iason, et al.
Publicado: (2022)

The Role of PROX1 in Neoplasia: A Key Player Often Overlooked
por: Ntikoudi, Evangelia, et al.
Publicado: (2022)

HuR Protein in Hepatocellular Carcinoma: Implications in Development, Prognosis and Treatment
por: Papatheofani, Vasiliki, et al.
Publicado: (2021)

Achieving the cancer moonshot in Africa
por: Adewole, Isaac, et al.
Publicado: (2022)

The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy?
por: Papadakos, Stavros P., et al.
Publicado: (2023)

Moonshot thinking in periodontology
por: Park, Jung-Chul, et al.
Publicado: (2021)

Exosomes on Endometrial Cancer: A Biomarkers Treasure Trove?
por: Sykaras, Alexandros G., et al.
Publicado: (2022)

Unraveling the Significance of EPH/Ephrin Signaling in Liver Cancer: Insights into Tumor Progression and Therapeutic Implications
por: Papadakos, Stavros P., et al.
Publicado: (2023)

Liquid Biopsy: A New Translational Diagnostic and Monitoring Tool for Musculoskeletal Tumors
por: Hadjimichael, Argyris C., et al.
Publicado: (2021)

Regulatory role of RNA modifications in the treatment of pancreatic ductal adenocarcinoma (PDAC)
por: Chen, Hao, et al.
Publicado: (2023)

The Impact of the Cancer Moonshot on Cardio-Oncology Science
por: Minasian, Lori M., et al.
Publicado: (2022)

Moonshot Science—Risks and Benefits
por: Casadevall, Arturo, et al.
Publicado: (2016)

The Impact of Angiogenesis in the Most Common Salivary Gland Malignant Tumors
por: Pouloudi, Despoina, et al.
Publicado: (2020)

Interplay of Extracellular Vesicles and TLR4 Signaling in Hepatocellular Carcinoma Pathophysiology and Therapeutics
por: Papadakos, Stavros P., et al.
Publicado: (2023)

The EPH/Ephrin System in Bone and Soft Tissue Sarcomas’ Pathogenesis and Therapy: New Advancements and a Literature Review
por: Hadjimichael, Argyris C., et al.
Publicado: (2022)

Modifiable Pancreatic Ductal Adenocarcinoma (PDAC) Risk Factors
por: Michalak, Natalia, et al.
Publicado: (2023)

Divulging the Critical Role of HuR in Pancreatic Cancer as a Therapeutic Target and a Means to Overcome Chemoresistance
por: Goutas, Dimitrios, et al.
Publicado: (2021)

Biological Hallmarks and New Therapeutic Approaches for the Treatment of PDAC
por: Digiacomo, Graziana, et al.
Publicado: (2021)

CEPI launches 100-day vaccine “moonshot”
por: Usher, Ann Danaiya
Publicado: (2022)

EPH/Ephrin Signaling in Normal Hematopoiesis and Hematologic Malignancies: Deciphering Their Intricate Role and Unraveling Possible New Therapeutic Targets
por: Stergiou, Ioanna E., et al.
Publicado: (2023)

Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?
por: Lagniau, Sabrina, et al.
Publicado: (2017)

The Role of Exosomes in Bone Remodeling: Implications for Bone Physiology and Disease
por: Masaoutis, Christos, et al.
Publicado: (2019)

A new phase of the Cancer Moonshot to end cancer as we know it
por: Singer, Dinah S.
Publicado: (2022)

Moonshots en la educación : nuevas tecnologías y aprendizaje mixto en el aula /
por: Wojcicki, Esther
Publicado: (2016)

The Role of TLR4 in the Immunotherapy of Hepatocellular Carcinoma: Can We Teach an Old Dog New Tricks?
por: Papadakos, Stavros P., et al.
Publicado: (2023)

The economics of moonshots: Value in rare disease drug development
por: Yates, Nathan, et al.
Publicado: (2022)

MicroRNAs as Indicators of Malignancy in Pancreatic Ductal Adenocarcinoma (PDAC) and Cystic Pancreatic Lesions
por: Prinz, Christian, et al.
Publicado: (2022)

Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC)
por: Le, Kai, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mlvh6pk0hobsucvsst3hnb618b